Yuanyi Mang

机构：Kunming Medical University, The First Hospital of Kunming · ORCID：0000-0001-6814-5917

发表论文 6 篇 · 总被引 709 次 · h-index 5

代表论文

• Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma (2023 · Molecular Cancer · 被引 320)
• Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3 (2023 · Molecular Biology Reports · 被引 32)
• MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24 (2023 · Life Sciences · 被引 26)
• Unraveling the Heterogeneity of CD8+ T-Cell Subsets in Liver Cirrhosis: Implications for Disease Progression (2024 · Gut and Liver · 被引 7)
• Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma (2023 · Clinical & Translational Oncology · 被引 4)